Found 20 matching trials
Restoration of Immunity to Vaccine Preventable Diseases After CART-T Cell Therapy N/A The goal of this observational study is to learn about vaccine immunity in ...
Show More Location
University Hospital Bern
Learn More & Join Trial
Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus (HPV) Vaccine With Other Vaccines in Healthy Female Subjects PHASE3 Infection with human papillomavirus (HPV) has been clearly established as t...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Comparison of GSK Biologicals' Reduced Antigen Diphtheria and Tetanus Toxoids and Acellular Pertussis- Inactivated Poliovirus Vaccine, to BoostrixTM and Inactivated Poliovirus Vaccine Administered Separately and With Revaxis® PHASE3 This study will assess the immunogenicity and reactogenicity of the candida...
Show More Location
Multiple Locations
Learn More & Join Trial
Immunogenicity and Safety of Meningococcal Vaccine GSK 134612 Co-administered With Pneumococcal and DTPa-HBV-IPV/Hib Vaccines PHASE3 The purpose of this study is to evaluate immunogenicity and safety of menin...
Show More Location
GSK Investigational Site
Learn More & Join Trial
The PertADO Geneva Trial PHASE2 This is a phase II, randomized double-center, and observer-blind controlled...
Show More Location
Pediatric clinical trial platform, University Hospitals of Geneva City: Geneva
Learn More & Join Trial
Study Evaluating Treatment of Fever in Children Who Have Been Vaccinated With Prevenar and Infanrix Hexa PHASE4 The purpose of the study is to determine whether prophylactic antipyretic t...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Assess the Immunogenicity and Safety of GSK Biologicals' Infanrix-IPV/Hib Vaccine Administered as a Three-dose Vaccination Course at 3, 4.5 and 6 Months of Age and a Booster Dose at 18 Months of Age in Healthy Infants in Russia PHASE3 The purpose of this study is to evaluate the immune response, safety and re...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety and Immunogenicity of a Booster Dose of GSK Biological's Boostrix-Polio Vaccine PHASE4 Subjects aged 9 to 13 years who participated in the 711866/001 study 5 year...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Safety and Immunogenicity of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) PHASE2 This study is designed to evaluate the safety and immunogenicity of new for...
Show More Location
GSK Investigational Site
Learn More & Join Trial
Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose PHASE2 The current trial will evaluate the safety and immunogenicity of GSK Biolog...
Show More Location
GSK Investigational Site
Learn More & Join Trial